Green Cross Health (NZSE:GXH) Beta: 1.1606 (As of Jul. 09, 2026)


NZSE:GXH Green Cross Health Ltd NZSE:GXH
63 GF Score
Price NZ$2.00
GF Value NZ$1.08
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Green Cross Health Beta?

Green Cross Health NZSE:GXH +1.01% 63 Beta is 1.1606 as of Jul. 09, 2026. GuruFocus rates NZSE:GXH with a GF Score™ of 63/100 and a GF Value™ of NZ$1.08 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-09), Green Cross Health's Beta is 1.1606.


Green Cross Health  (NZSE:GXH) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Green Cross Health Beta Related Terms


Green Cross Health Beta Historical Data

* Premium members only.

The historical data trend for Green Cross Health's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Green Cross Health Beta Chart

Green Cross Health Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 -0.07 -0.04 0.65 0.87

Green Cross Health Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 0.47 0.65 1.10 0.87

Green Cross Health Beta Competitor Comparison

For the Pharmaceutical Retailers subindustry, Green Cross Health's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Cross Health Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Green Cross Health's Beta distribution charts can be found below:

* The bar in red indicates where Green Cross Health's Beta falls into.


NZSE:GXH
63GF Score
Green Cross Health Ltd NZSE:GXH
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Green Cross Health Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1606 mean?
Green Cross Health (NZSE:GXH) has a Beta of 1.1606 as of Jul. 09, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Green Cross Health and its competitors.
Is Green Cross Health's Beta too high?
Green Cross Health's current Beta is 1.1606. Overall, Green Cross Health has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's Beta compare to competitors?
Green Cross Health's Beta of 1.1606 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Green Cross Health and its competitors. Green Cross Health's current Beta is 1.1606. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$2.00 — trading 85.2% above its estimated fair value. The current Beta is 1.1606. Green Cross Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current Beta is 1.1606 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Green Cross Health (NZSE:GXH) Overvalued in 2026?

Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued. The current stock price of NZ$2.00 is trading 85.2% above its estimated GF Value™ of NZ$1.08. GuruFocus considers Green Cross Health to be Significantly Overvalued.

Key valuation signals for NZSE:GXH:

  • Beta: 1.1606
  • GF Value™: NZ$1.08 vs. price of NZ$2.00 (85.2% above fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Green Cross Health Business Description

Address 602 Great South Road, Ellerslie, Ground Floor, Building B, Millennium Centre, Auckland, NTL, NZL, 1051
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
63GF Score

Get the complete analysis for NZSE:GXH

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$2.00
Price
NZ$1.08
GF Value